nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Fluid overload—Carbachol—glaucoma	0.0193	0.0267	CcSEcCtD
Terlipressin—Abdominal cramps—Carbachol—glaucoma	0.0178	0.0246	CcSEcCtD
Terlipressin—Bradycardia—Physostigmine—glaucoma	0.0144	0.02	CcSEcCtD
Terlipressin—Peripheral ischaemia—Betaxolol—glaucoma	0.0129	0.0179	CcSEcCtD
Terlipressin—Respiratory failure—Carteolol—glaucoma	0.0127	0.0176	CcSEcCtD
Terlipressin—Respiratory failure—Levobunolol—glaucoma	0.012	0.0167	CcSEcCtD
Terlipressin—Respiratory distress—Dorzolamide—glaucoma	0.0113	0.0157	CcSEcCtD
Terlipressin—Cyanosis—Brimonidine—glaucoma	0.0106	0.0147	CcSEcCtD
Terlipressin—Pallor—Apraclonidine—glaucoma	0.0106	0.0146	CcSEcCtD
Terlipressin—Atrial fibrillation—Metipranolol—glaucoma	0.0103	0.0143	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—OPN4—glaucoma	0.00941	0.0337	CbGpPWpGaD
Terlipressin—Pallor—Brimonidine—glaucoma	0.00906	0.0126	CcSEcCtD
Terlipressin—Hypertension—Dipivefrin—glaucoma	0.00905	0.0126	CcSEcCtD
Terlipressin—Hyponatraemia—Carbachol—glaucoma	0.00873	0.0121	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—PTGFR—glaucoma	0.00848	0.0304	CbGpPWpGaD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00842	0.0301	CbGpPWpGaD
Terlipressin—Tachycardia—Dipivefrin—glaucoma	0.00835	0.0116	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00796	0.0285	CbGpPWpGaD
Terlipressin—Respiratory failure—Brimonidine—glaucoma	0.00765	0.0106	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00758	0.0271	CbGpPWpGaD
Terlipressin—Acute coronary syndrome—Metipranolol—glaucoma	0.00743	0.0103	CcSEcCtD
Terlipressin—Respiratory distress—Betaxolol—glaucoma	0.00742	0.0103	CcSEcCtD
Terlipressin—Myocardial infarction—Metipranolol—glaucoma	0.00739	0.0103	CcSEcCtD
Terlipressin—Respiratory failure—Dorzolamide—glaucoma	0.0073	0.0101	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00728	0.0261	CbGpPWpGaD
Terlipressin—Bradycardia—Metipranolol—glaucoma	0.00689	0.00956	CcSEcCtD
Terlipressin—AVPR1B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00655	0.0235	CbGpPWpGaD
Terlipressin—Pallor—Clonidine—glaucoma	0.00653	0.00906	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—OPN4—glaucoma	0.00652	0.0234	CbGpPWpGaD
Terlipressin—Vomiting—Physostigmine—glaucoma	0.0064	0.00888	CcSEcCtD
Terlipressin—Pulmonary oedema—Dorzolamide—glaucoma	0.00638	0.00886	CcSEcCtD
Terlipressin—Bradycardia—Carteolol—glaucoma	0.00638	0.00886	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00623	0.0223	CbGpPWpGaD
Terlipressin—Respiratory distress—Timolol—glaucoma	0.00606	0.00841	CcSEcCtD
Terlipressin—Bradycardia—Levobunolol—glaucoma	0.00603	0.00837	CcSEcCtD
Terlipressin—Pulmonary oedema—Pilocarpine—glaucoma	0.00603	0.00837	CcSEcCtD
Terlipressin—Nausea—Physostigmine—glaucoma	0.00598	0.00829	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—PTGFR—glaucoma	0.00587	0.021	CbGpPWpGaD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00584	0.0209	CbGpPWpGaD
Terlipressin—Hyponatraemia—Acetazolamide—glaucoma	0.0057	0.00791	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00561	0.0201	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00551	0.0197	CbGpPWpGaD
Terlipressin—Respiratory failure—Clonidine—glaucoma	0.00551	0.00765	CcSEcCtD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00548	0.0196	CbGpPWpGaD
Terlipressin—Cardiac failure—Dorzolamide—glaucoma	0.00533	0.0074	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00525	0.0188	CbGpPWpGaD
Terlipressin—Hypertension—Metipranolol—glaucoma	0.00509	0.00706	CcSEcCtD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00504	0.0181	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00501	0.0179	CbGpPWpGaD
Terlipressin—Respiratory failure—Betaxolol—glaucoma	0.0048	0.00666	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—OPN4—glaucoma	0.00475	0.017	CbGpPWpGaD
Terlipressin—AVPR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00454	0.0163	CbGpPWpGaD
Terlipressin—AVPR2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00451	0.0161	CbGpPWpGaD
Terlipressin—Bradycardia—Apraclonidine—glaucoma	0.00447	0.0062	CcSEcCtD
Terlipressin—Chest pain—Levobunolol—glaucoma	0.00439	0.00609	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00432	0.0155	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00429	0.0154	CbGpPWpGaD
Terlipressin—Dyspnoea—Metipranolol—glaucoma	0.00429	0.00595	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—PTGFR—glaucoma	0.00427	0.0153	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—PEX19—glaucoma	0.00409	0.0147	CbGpPWpGaD
Terlipressin—Chest pain—Latanoprost—glaucoma	0.00407	0.00565	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.00404	0.00561	CcSEcCtD
Terlipressin—Angiopathy—Apraclonidine—glaucoma	0.00399	0.00553	CcSEcCtD
Terlipressin—Dyspnoea—Carteolol—glaucoma	0.00397	0.00551	CcSEcCtD
Terlipressin—Acute coronary syndrome—Dorzolamide—glaucoma	0.00396	0.00549	CcSEcCtD
Terlipressin—Myocardial infarction—Dorzolamide—glaucoma	0.00393	0.00546	CcSEcCtD
Terlipressin—Respiratory failure—Timolol—glaucoma	0.00392	0.00544	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00389	0.0139	CbGpPWpGaD
Terlipressin—Angiopathy—Bimatoprost—glaucoma	0.00386	0.00536	CcSEcCtD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00386	0.0138	CbGpPWpGaD
Terlipressin—Bradycardia—Brimonidine—glaucoma	0.00384	0.00533	CcSEcCtD
Terlipressin—Nervous system disorder—Latanoprost—glaucoma	0.00383	0.00531	CcSEcCtD
Terlipressin—Skin disorder—Latanoprost—glaucoma	0.00379	0.00526	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00378	0.00525	CcSEcCtD
Terlipressin—Dyspnoea—Levobunolol—glaucoma	0.00375	0.00521	CcSEcCtD
Terlipressin—Acute coronary syndrome—Pilocarpine—glaucoma	0.00374	0.00519	CcSEcCtD
Terlipressin—Myocardial infarction—Pilocarpine—glaucoma	0.00372	0.00516	CcSEcCtD
Terlipressin—Bradycardia—Dorzolamide—glaucoma	0.00367	0.00509	CcSEcCtD
Terlipressin—Bradycardia—Travoprost—glaucoma	0.00365	0.00507	CcSEcCtD
Terlipressin—Bradycardia—Brinzolamide—glaucoma	0.0036	0.005	CcSEcCtD
Terlipressin—Cardiac failure—Betaxolol—glaucoma	0.0035	0.00486	CcSEcCtD
Terlipressin—Cardiac disorder—Brimonidine—glaucoma	0.0035	0.00486	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Methazolamide—glaucoma	0.00348	0.00483	CcSEcCtD
Terlipressin—Dyspnoea—Latanoprost—glaucoma	0.00348	0.00483	CcSEcCtD
Terlipressin—Bradycardia—Pilocarpine—glaucoma	0.00346	0.00481	CcSEcCtD
Terlipressin—Pulmonary oedema—Timolol—glaucoma	0.00343	0.00475	CcSEcCtD
Terlipressin—Angiopathy—Brimonidine—glaucoma	0.00342	0.00475	CcSEcCtD
Terlipressin—Abdominal pain—Carbachol—glaucoma	0.00338	0.00469	CcSEcCtD
Terlipressin—Cardiac disorder—Travoprost—glaucoma	0.00333	0.00462	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—OPN4—glaucoma	0.00329	0.0118	CbGpPWpGaD
Terlipressin—Cardiac disorder—Brinzolamide—glaucoma	0.00329	0.00456	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—OPN4—glaucoma	0.00327	0.0117	CbGpPWpGaD
Terlipressin—Chest pain—Apraclonidine—glaucoma	0.00326	0.00452	CcSEcCtD
Terlipressin—Angiopathy—Travoprost—glaucoma	0.00325	0.00451	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00323	0.00449	CcSEcCtD
Terlipressin—Angiopathy—Brinzolamide—glaucoma	0.00321	0.00446	CcSEcCtD
Terlipressin—Hypertension—Bimatoprost—glaucoma	0.0032	0.00444	CcSEcCtD
Terlipressin—Chest pain—Bimatoprost—glaucoma	0.00316	0.00438	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.00313	0.00435	CcSEcCtD
Terlipressin—Malnutrition—Brinzolamide—glaucoma	0.00308	0.00428	CcSEcCtD
Terlipressin—Nervous system disorder—Apraclonidine—glaucoma	0.00306	0.00425	CcSEcCtD
Terlipressin—Skin disorder—Apraclonidine—glaucoma	0.00303	0.00421	CcSEcCtD
Terlipressin—Headache—Metipranolol—glaucoma	0.00301	0.00418	CcSEcCtD
Terlipressin—Nervous system disorder—Bimatoprost—glaucoma	0.00297	0.00412	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—PTGFR—glaucoma	0.00296	0.0106	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—PTGFR—glaucoma	0.00294	0.0105	CbGpPWpGaD
Terlipressin—Skin disorder—Bimatoprost—glaucoma	0.00294	0.00408	CcSEcCtD
Terlipressin—Diarrhoea—Carbachol—glaucoma	0.00293	0.00406	CcSEcCtD
Terlipressin—Diarrhoea—Levobunolol—glaucoma	0.00288	0.004	CcSEcCtD
Terlipressin—Cardiac failure—Timolol—glaucoma	0.00286	0.00397	CcSEcCtD
Terlipressin—Nausea—Metipranolol—glaucoma	0.00286	0.00396	CcSEcCtD
Terlipressin—Hypertension—Brimonidine—glaucoma	0.00283	0.00393	CcSEcCtD
Terlipressin—AVPR1B—G alpha (q) signalling events—EDN1—glaucoma	0.00282	0.0101	CbGpPWpGaD
Terlipressin—Chest pain—Brimonidine—glaucoma	0.00279	0.00388	CcSEcCtD
Terlipressin—Headache—Carteolol—glaucoma	0.00279	0.00387	CcSEcCtD
Terlipressin—Vomiting—Diclofenamide—glaucoma	0.00278	0.00386	CcSEcCtD
Terlipressin—Dyspnoea—Apraclonidine—glaucoma	0.00278	0.00386	CcSEcCtD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—EDN1—glaucoma	0.00278	0.00996	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.00278	0.00385	CcSEcCtD
Terlipressin—Bradycardia—Clonidine—glaucoma	0.00277	0.00384	CcSEcCtD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.00277	0.0099	CbGpPWpGaD
Terlipressin—Diarrhoea—Methazolamide—glaucoma	0.00276	0.00383	CcSEcCtD
Terlipressin—Headache—Diclofenamide—glaucoma	0.00274	0.00381	CcSEcCtD
Terlipressin—Vomiting—Carbachol—glaucoma	0.00272	0.00377	CcSEcCtD
Terlipressin—Hypertension—Dorzolamide—glaucoma	0.00271	0.00376	CcSEcCtD
Terlipressin—Dyspnoea—Bimatoprost—glaucoma	0.0027	0.00374	CcSEcCtD
Terlipressin—Hypertension—Travoprost—glaucoma	0.0027	0.00374	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00269	0.00374	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—OPN4—glaucoma	0.00268	0.00961	CbGpPWpGaD
Terlipressin—Headache—Carbachol—glaucoma	0.00268	0.00372	CcSEcCtD
Terlipressin—Chest pain—Dorzolamide—glaucoma	0.00267	0.0037	CcSEcCtD
Terlipressin—Hypertension—Brinzolamide—glaucoma	0.00266	0.00369	CcSEcCtD
Terlipressin—Chest pain—Travoprost—glaucoma	0.00266	0.00369	CcSEcCtD
Terlipressin—Nausea—Carteolol—glaucoma	0.00265	0.00367	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.00264	0.00366	CcSEcCtD
Terlipressin—Headache—Levobunolol—glaucoma	0.00264	0.00366	CcSEcCtD
Terlipressin—Nervous system disorder—Brimonidine—glaucoma	0.00263	0.00365	CcSEcCtD
Terlipressin—Chest pain—Brinzolamide—glaucoma	0.00262	0.00364	CcSEcCtD
Terlipressin—Tachycardia—Brimonidine—glaucoma	0.00261	0.00363	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00261	0.00362	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.00261	0.00362	CcSEcCtD
Terlipressin—Skin disorder—Brimonidine—glaucoma	0.0026	0.00361	CcSEcCtD
Terlipressin—Nausea—Diclofenamide—glaucoma	0.0026	0.00361	CcSEcCtD
Terlipressin—Acute coronary syndrome—Betaxolol—glaucoma	0.0026	0.0036	CcSEcCtD
Terlipressin—Myocardial infarction—Betaxolol—glaucoma	0.00258	0.00358	CcSEcCtD
Terlipressin—Vomiting—Methazolamide—glaucoma	0.00256	0.00356	CcSEcCtD
Terlipressin—Hypertension—Pilocarpine—glaucoma	0.00256	0.00355	CcSEcCtD
Terlipressin—Nausea—Carbachol—glaucoma	0.00254	0.00352	CcSEcCtD
Terlipressin—Headache—Methazolamide—glaucoma	0.00253	0.00351	CcSEcCtD
Terlipressin—Cardiac disorder—Clonidine—glaucoma	0.00252	0.0035	CcSEcCtD
Terlipressin—Chest pain—Pilocarpine—glaucoma	0.00252	0.0035	CcSEcCtD
Terlipressin—AVPR1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.00252	0.00902	CbGpPWpGaD
Terlipressin—Nausea—Levobunolol—glaucoma	0.0025	0.00347	CcSEcCtD
Terlipressin—Nervous system disorder—Travoprost—glaucoma	0.0025	0.00347	CcSEcCtD
Terlipressin—Tachycardia—Travoprost—glaucoma	0.00249	0.00345	CcSEcCtD
Terlipressin—Skin disorder—Travoprost—glaucoma	0.00247	0.00343	CcSEcCtD
Terlipressin—Abdominal pain—Apraclonidine—glaucoma	0.00247	0.00342	CcSEcCtD
Terlipressin—Nervous system disorder—Brinzolamide—glaucoma	0.00247	0.00342	CcSEcCtD
Terlipressin—Angiopathy—Clonidine—glaucoma	0.00247	0.00342	CcSEcCtD
Terlipressin—Tachycardia—Brinzolamide—glaucoma	0.00246	0.00341	CcSEcCtD
Terlipressin—Headache—Latanoprost—glaucoma	0.00245	0.00339	CcSEcCtD
Terlipressin—Skin disorder—Brinzolamide—glaucoma	0.00244	0.00339	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—OPN4—glaucoma	0.00244	0.00872	CbGpPWpGaD
Terlipressin—AVPR1B—Peptide ligand-binding receptors—C3—glaucoma	0.00243	0.0087	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PTGFR—glaucoma	0.00242	0.00865	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00241	0.00334	CcSEcCtD
Terlipressin—Bradycardia—Betaxolol—glaucoma	0.00241	0.00334	CcSEcCtD
Terlipressin—Nausea—Methazolamide—glaucoma	0.0024	0.00332	CcSEcCtD
Terlipressin—Dyspnoea—Brimonidine—glaucoma	0.00239	0.00331	CcSEcCtD
Terlipressin—Tachycardia—Pilocarpine—glaucoma	0.00236	0.00327	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Brimonidine—glaucoma	0.00231	0.00321	CcSEcCtD
Terlipressin—Dyspnoea—Dorzolamide—glaucoma	0.00228	0.00317	CcSEcCtD
Terlipressin—Dyspnoea—Travoprost—glaucoma	0.00227	0.00315	CcSEcCtD
Terlipressin—Dyspnoea—Brinzolamide—glaucoma	0.00224	0.00311	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Travoprost—glaucoma	0.0022	0.00305	CcSEcCtD
Terlipressin—Cardiac disorder—Betaxolol—glaucoma	0.0022	0.00305	CcSEcCtD
Terlipressin—AVPR1B—Signaling by GPCR—PTGFR—glaucoma	0.00219	0.00786	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00217	0.00301	CcSEcCtD
Terlipressin—Dyspnoea—Pilocarpine—glaucoma	0.00216	0.00299	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—SMO—glaucoma	0.00216	0.00772	CbGpPWpGaD
Terlipressin—Angiopathy—Betaxolol—glaucoma	0.00215	0.00298	CcSEcCtD
Terlipressin—Diarrhoea—Apraclonidine—glaucoma	0.00214	0.00296	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00209	0.0029	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—LRP12—glaucoma	0.00208	0.00744	CbGpPWpGaD
Terlipressin—Malnutrition—Betaxolol—glaucoma	0.00206	0.00286	CcSEcCtD
Terlipressin—Abdominal pain—Dorzolamide—glaucoma	0.00202	0.00281	CcSEcCtD
Terlipressin—Chest pain—Clonidine—glaucoma	0.00201	0.00279	CcSEcCtD
Terlipressin—Abdominal pain—Travoprost—glaucoma	0.00201	0.00279	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.002	0.00278	CcSEcCtD
Terlipressin—Vomiting—Apraclonidine—glaucoma	0.00198	0.00275	CcSEcCtD
Terlipressin—Bradycardia—Timolol—glaucoma	0.00197	0.00273	CcSEcCtD
Terlipressin—Headache—Apraclonidine—glaucoma	0.00196	0.00271	CcSEcCtD
Terlipressin—AVPR1A—G alpha (q) signalling events—EDN1—glaucoma	0.00195	0.00699	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—EDN1—glaucoma	0.00193	0.00691	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—EDN1—glaucoma	0.00191	0.00686	CbGpPWpGaD
Terlipressin—Abdominal pain—Pilocarpine—glaucoma	0.00191	0.00265	CcSEcCtD
Terlipressin—Diarrhoea—Acetazolamide—glaucoma	0.00191	0.00265	CcSEcCtD
Terlipressin—Headache—Bimatoprost—glaucoma	0.0019	0.00263	CcSEcCtD
Terlipressin—Nervous system disorder—Clonidine—glaucoma	0.00189	0.00263	CcSEcCtD
Terlipressin—Tachycardia—Clonidine—glaucoma	0.00188	0.00261	CcSEcCtD
Terlipressin—Skin disorder—Clonidine—glaucoma	0.00188	0.0026	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00187	0.00668	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—OPN4—glaucoma	0.00186	0.00666	CbGpPWpGaD
Terlipressin—Nausea—Apraclonidine—glaucoma	0.00185	0.00257	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—OPN4—glaucoma	0.00185	0.00661	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.00184	0.00661	CbGpPWpGaD
Terlipressin—Nausea—Bimatoprost—glaucoma	0.0018	0.00249	CcSEcCtD
Terlipressin—Cardiac disorder—Timolol—glaucoma	0.00179	0.00249	CcSEcCtD
Terlipressin—Vomiting—Acetazolamide—glaucoma	0.00177	0.00246	CcSEcCtD
Terlipressin—Angiopathy—Timolol—glaucoma	0.00175	0.00243	CcSEcCtD
Terlipressin—Chest pain—Betaxolol—glaucoma	0.00175	0.00243	CcSEcCtD
Terlipressin—Diarrhoea—Dorzolamide—glaucoma	0.00175	0.00243	CcSEcCtD
Terlipressin—Headache—Acetazolamide—glaucoma	0.00175	0.00243	CcSEcCtD
Terlipressin—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.00175	0.00626	CbGpPWpGaD
Terlipressin—Diarrhoea—Travoprost—glaucoma	0.00174	0.00242	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.00174	0.00242	CcSEcCtD
Terlipressin—Dyspnoea—Clonidine—glaucoma	0.00172	0.00239	CcSEcCtD
Terlipressin—Diarrhoea—Brinzolamide—glaucoma	0.00172	0.00239	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—OPN4—glaucoma	0.00169	0.00605	CbGpPWpGaD
Terlipressin—AVPR1A—Peptide ligand-binding receptors—C3—glaucoma	0.00168	0.00603	CbGpPWpGaD
Terlipressin—Malnutrition—Timolol—glaucoma	0.00168	0.00233	CcSEcCtD
Terlipressin—Headache—Brimonidine—glaucoma	0.00168	0.00233	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—OPN4—glaucoma	0.00168	0.006	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PTGFR—glaucoma	0.00167	0.006	CbGpPWpGaD
Terlipressin—AVPR2—Peptide ligand-binding receptors—C3—glaucoma	0.00167	0.00599	CbGpPWpGaD
Terlipressin—Gastrointestinal disorder—Clonidine—glaucoma	0.00167	0.00231	CcSEcCtD
Terlipressin—AVPR2—GPCR downstream signaling—PTGFR—glaucoma	0.00166	0.00595	CbGpPWpGaD
Terlipressin—Nausea—Acetazolamide—glaucoma	0.00166	0.0023	CcSEcCtD
Terlipressin—Diarrhoea—Pilocarpine—glaucoma	0.00165	0.0023	CcSEcCtD
Terlipressin—Nervous system disorder—Betaxolol—glaucoma	0.00165	0.00229	CcSEcCtD
Terlipressin—Tachycardia—Betaxolol—glaucoma	0.00164	0.00228	CcSEcCtD
Terlipressin—Skin disorder—Betaxolol—glaucoma	0.00163	0.00227	CcSEcCtD
Terlipressin—AVPR1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00163	0.00584	CbGpPWpGaD
Terlipressin—Vomiting—Dorzolamide—glaucoma	0.00163	0.00226	CcSEcCtD
Terlipressin—Headache—Dorzolamide—glaucoma	0.0016	0.00222	CcSEcCtD
Terlipressin—Vomiting—Brinzolamide—glaucoma	0.0016	0.00222	CcSEcCtD
Terlipressin—Headache—Travoprost—glaucoma	0.0016	0.00221	CcSEcCtD
Terlipressin—Nausea—Brimonidine—glaucoma	0.00159	0.00221	CcSEcCtD
Terlipressin—Headache—Brinzolamide—glaucoma	0.00158	0.00219	CcSEcCtD
Terlipressin—Vomiting—Pilocarpine—glaucoma	0.00154	0.00213	CcSEcCtD
Terlipressin—Abdominal pain—Clonidine—glaucoma	0.00153	0.00212	CcSEcCtD
Terlipressin—AVPR1A—Signaling by GPCR—PTGFR—glaucoma	0.00152	0.00544	CbGpPWpGaD
Terlipressin—Nausea—Dorzolamide—glaucoma	0.00152	0.00211	CcSEcCtD
Terlipressin—Headache—Pilocarpine—glaucoma	0.00151	0.0021	CcSEcCtD
Terlipressin—Nausea—Travoprost—glaucoma	0.00151	0.0021	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—PTGFR—glaucoma	0.00151	0.00541	CbGpPWpGaD
Terlipressin—Dyspnoea—Betaxolol—glaucoma	0.0015	0.00208	CcSEcCtD
Terlipressin—Nausea—Brinzolamide—glaucoma	0.00149	0.00207	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—SMO—glaucoma	0.00149	0.00535	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—SMO—glaucoma	0.00148	0.00531	CbGpPWpGaD
Terlipressin—Hypertension—Timolol—glaucoma	0.00145	0.00202	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Betaxolol—glaucoma	0.00145	0.00201	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—OPN4—glaucoma	0.00144	0.00515	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—LRP12—glaucoma	0.00144	0.00515	CbGpPWpGaD
Terlipressin—Nausea—Pilocarpine—glaucoma	0.00144	0.00199	CcSEcCtD
Terlipressin—Chest pain—Timolol—glaucoma	0.00143	0.00199	CcSEcCtD
Terlipressin—AVPR2—Signaling Pathways—LRP12—glaucoma	0.00143	0.00512	CbGpPWpGaD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00142	0.00197	CcSEcCtD
Terlipressin—AVPR1B—GPCR ligand binding—EDN1—glaucoma	0.00142	0.00509	CbGpPWpGaD
Terlipressin—AVPR2—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.00135	0.00484	CbGpPWpGaD
Terlipressin—Nervous system disorder—Timolol—glaucoma	0.00135	0.00187	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—HEYL—glaucoma	0.00134	0.00479	CbGpPWpGaD
Terlipressin—Skin disorder—Timolol—glaucoma	0.00133	0.00185	CcSEcCtD
Terlipressin—Diarrhoea—Clonidine—glaucoma	0.00132	0.00183	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—PTGFR—glaucoma	0.0013	0.00464	CbGpPWpGaD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00129	0.00463	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00128	0.0046	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR ligand binding—C3—glaucoma	0.00124	0.00445	CbGpPWpGaD
Terlipressin—Vomiting—Clonidine—glaucoma	0.00123	0.0017	CcSEcCtD
Terlipressin—Dyspnoea—Timolol—glaucoma	0.00122	0.0017	CcSEcCtD
Terlipressin—Headache—Clonidine—glaucoma	0.00121	0.00168	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Timolol—glaucoma	0.00119	0.00164	CcSEcCtD
Terlipressin—Diarrhoea—Betaxolol—glaucoma	0.00115	0.0016	CcSEcCtD
Terlipressin—Nausea—Clonidine—glaucoma	0.00115	0.00159	CcSEcCtD
Terlipressin—AVPR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00113	0.00405	CbGpPWpGaD
Terlipressin—AVPR2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00112	0.00402	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—SMO—glaucoma	0.00111	0.00396	CbGpPWpGaD
Terlipressin—Abdominal pain—Timolol—glaucoma	0.00109	0.00151	CcSEcCtD
Terlipressin—Vomiting—Betaxolol—glaucoma	0.00107	0.00148	CcSEcCtD
Terlipressin—Headache—Betaxolol—glaucoma	0.00105	0.00146	CcSEcCtD
Terlipressin—AVPR1B—Signaling Pathways—RPTOR—glaucoma	0.00101	0.00363	CbGpPWpGaD
Terlipressin—Nausea—Betaxolol—glaucoma	0.000999	0.00139	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—OPN4—glaucoma	0.000998	0.00357	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—OPN4—glaucoma	0.00099	0.00355	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR ligand binding—EDN1—glaucoma	0.000985	0.00353	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NCK2—glaucoma	0.000982	0.00352	CbGpPWpGaD
Terlipressin—AVPR2—GPCR ligand binding—EDN1—glaucoma	0.000978	0.0035	CbGpPWpGaD
Terlipressin—Diarrhoea—Timolol—glaucoma	0.00094	0.0013	CcSEcCtD
Terlipressin—AVPR1A—Signaling Pathways—HEYL—glaucoma	0.000927	0.00332	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HEYL—glaucoma	0.000921	0.0033	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTGFR—glaucoma	0.000898	0.00322	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTGFR—glaucoma	0.000892	0.00319	CbGpPWpGaD
Terlipressin—Vomiting—Timolol—glaucoma	0.000873	0.00121	CcSEcCtD
Terlipressin—AVPR1A—GPCR ligand binding—C3—glaucoma	0.00086	0.00308	CbGpPWpGaD
Terlipressin—Headache—Timolol—glaucoma	0.00086	0.00119	CcSEcCtD
Terlipressin—AVPR2—GPCR ligand binding—C3—glaucoma	0.000854	0.00306	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HDAC9—glaucoma	0.000835	0.00299	CbGpPWpGaD
Terlipressin—Nausea—Timolol—glaucoma	0.000816	0.00113	CcSEcCtD
Terlipressin—AVPR1B—GPCR downstream signaling—EDN1—glaucoma	0.000803	0.00288	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—SMO—glaucoma	0.000767	0.00275	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—SMO—glaucoma	0.000761	0.00273	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EDN1—glaucoma	0.000729	0.00261	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RPTOR—glaucoma	0.000703	0.00252	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—C3—glaucoma	0.000702	0.00251	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RPTOR—glaucoma	0.000698	0.0025	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NCK2—glaucoma	0.000681	0.00244	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NCK2—glaucoma	0.000676	0.00242	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SMO—glaucoma	0.000653	0.00234	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—C3—glaucoma	0.000637	0.00228	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NTRK2—glaucoma	0.000598	0.00214	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HDAC9—glaucoma	0.000579	0.00207	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HDAC9—glaucoma	0.000575	0.00206	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—EDN1—glaucoma	0.000557	0.00199	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—EDN1—glaucoma	0.000553	0.00198	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NGFR—glaucoma	0.000513	0.00184	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EDN1—glaucoma	0.000505	0.00181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EDN1—glaucoma	0.000502	0.0018	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NTRK1—glaucoma	0.000487	0.00174	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—C3—glaucoma	0.000486	0.00174	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—C3—glaucoma	0.000483	0.00173	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SMO—glaucoma	0.000453	0.00162	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SMO—glaucoma	0.00045	0.00161	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN2B—glaucoma	0.000449	0.00161	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—C3—glaucoma	0.000442	0.00158	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—C3—glaucoma	0.000438	0.00157	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EDN1—glaucoma	0.000431	0.00154	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NTRK2—glaucoma	0.000414	0.00148	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NTRK2—glaucoma	0.000411	0.00147	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NGF—glaucoma	0.000396	0.00142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—C3—glaucoma	0.000376	0.00135	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NGFR—glaucoma	0.000355	0.00127	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NGFR—glaucoma	0.000353	0.00126	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APOE—glaucoma	0.00035	0.00125	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CAV1—glaucoma	0.000347	0.00124	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NTRK1—glaucoma	0.000338	0.00121	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NTRK1—glaucoma	0.000335	0.0012	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FN1—glaucoma	0.00033	0.00118	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BAD—glaucoma	0.000326	0.00117	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN2B—glaucoma	0.000311	0.00111	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN2B—glaucoma	0.000309	0.00111	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EDN1—glaucoma	0.000299	0.00107	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EDN1—glaucoma	0.000296	0.00106	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NGF—glaucoma	0.000274	0.000983	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NGF—glaucoma	0.000272	0.000976	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOS3—glaucoma	0.000262	0.00094	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—C3—glaucoma	0.000261	0.000934	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—C3—glaucoma	0.000259	0.000927	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APOE—glaucoma	0.000243	0.00087	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APOE—glaucoma	0.000241	0.000863	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CAV1—glaucoma	0.000241	0.000862	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CAV1—glaucoma	0.000239	0.000855	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FN1—glaucoma	0.000229	0.00082	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FN1—glaucoma	0.000227	0.000814	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—glaucoma	0.000227	0.000814	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BAD—glaucoma	0.000226	0.00081	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BAD—glaucoma	0.000225	0.000805	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—glaucoma	0.000211	0.000754	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—glaucoma	0.000189	0.000677	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOS3—glaucoma	0.000182	0.000652	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOS3—glaucoma	0.000181	0.000647	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—glaucoma	0.000158	0.000564	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—glaucoma	0.000156	0.00056	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—glaucoma	0.000146	0.000523	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—glaucoma	0.000145	0.000519	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—glaucoma	0.000143	0.000512	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—glaucoma	0.000131	0.000469	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—glaucoma	0.00013	0.000466	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—glaucoma	9.9e-05	0.000355	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—glaucoma	9.83e-05	0.000352	CbGpPWpGaD
